reader comments 46 Amylyx, the maker of a new drug to treat ALS, is pulling that drug from the market and laying off 70 percent of its workers after a large clinical trial found that the drug did not help patients, according to an announcement from the company Thursday. The drug, Relyvrio, won approval from ..
Tag : clinical trial
Enlarge / A father cares for his 8-and-a-half-month-old son, who is in the intensive care unit of the pediatric clinic at St. Joseph Hospital in Berlin with a respiratory infection and is receiving non-invasive ventilation (CPAP ventilation). reader comments 24 with A committee of independent expert advisers for the Food and Drug Administration on Thursday ..
Enlarge / Laboratory technicians in France prepare stool to treat patients with serious colon infections by fecal microbiota transplantation (FMT), also known as gut flora transplant (GFT) in 2019. reader comments 117 with 0 posters participating Share this story For the first time, the US Food and Drug Administration has granted approval for a feces-based ..
Enlarge / Empty vials of the Novavax Inc. Nuvaxovid COVID-19 vaccine arranged at the Tegel Vaccine Center in Berlin, Germany, on Monday, March 7, 2022. reader comments 65 with 49 posters participating Share this story A committee of independent, expert advisors for the Food and Drug Administration voted overwhelmingly in favor of authorizing the two-dose ..
Enlarge / A vial of the current Moderna COVID-19 vaccine. reader comments 39 with 28 posters participating Share this story Covid-19 Coverage View more stories Mild or not, more SARS-CoV-2 variants are inevitable. To avoid any blips in our pandemic endgame, researchers at the National Institutes of Health on Thursday announced the start of a ..
Enlarge / Tablets of ivermectin. reader comments 362 with 154 posters participating Share this story The antiparasitic drug ivermectin failed to treat COVID-19 in yet another randomized clinical trial, but the drug remains popular amid the pandemic thanks to Republican politics. That’s the takeaway from two separate studies published Friday in JAMA Internal Medicine. Together, ..
Enlarge / Scenes like this might become less common if a new SARS-CoV-2 protease inhibitor becomes widely available. reader comments 70 with 48 posters participating Share this story Covid-19 Coverage View more stories On Monday, pharmaceutical giant Pfizer released more data on its anti-COVID-19 drug, named Paxlovid. The company had released its initial data on ..
Enlarge / A Merck sign stands in front of the company’s building on October 2, 2013, in Summit, New Jersey. reader comments 118 with 63 posters participating Share this story In a 13-to-10 vote, advisors for the Food and Drug Administration narrowly supported authorizing Merck’s Thor-inspired antiviral pill molnupiravir for use against severe COVID-19. The ..
Enlarge / A vial of the current Moderna COVID-19 vaccine. reader comments 50 with 39 posters participating Share this story Covid-19 Coverage View more stories Researchers have given out the first jabs of a tweaked version of Moderna’s COVID-19 vaccine, one aimed at fighting one of the most concerning coronavirus variants—the B.1.351 variant, first identified ..
Enlarge / A vial of the AstraZeneca/Oxford vaccine is pictured at a coronavirus vaccination center at the Wanda Metropolitano stadium in Madrid on March 24, 2021. reader comments 73 with 54 posters participating Share this story Covid-19 Coverage View more stories Brushing aside a dramatic rebuke from government researchers and independent experts, AstraZeneca on Wednesday ..